BridgeBio Oncology Therapeutics Inc. (BBOT) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BridgeBio Oncology Therap...

    NASDAQ: BBOT · Real-Time Price · USD
    12.36
    -0.08 (-0.64%)
    At close: Oct 03, 2025, 3:59 PM
    12.60
    1.94%
    After-hours: Oct 03, 2025, 07:57 PM EDT

    BridgeBio Oncology Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 22.98 -5.01K -59.3K -4.81K
    PEG Ratio
    		 -0.00 n/a 593.02 n/a
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 0.93 -3.28K -9.54K -11.37K
    P/FCF Ratio
    		 -228.69 n/a n/a n/a
    P/OCF Ratio
    		 -228.69 n/a n/a n/a
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a -1.1 -1.97 -2.01
    Quick Ratio
    		 10.40 n/a n/a n/a
    Current Ratio
    		 10.40 n/a n/a n/a
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 0.04 0.66 0.16 2.36
    Return on Assets
    		 0.04 -0.13 -0.02 -0.3
    Return on Invested Capital
    		 n/a -6.39 n/a -2.33
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist